Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: An open-label, Single-arm, Phase 2 study

John Farley, William E. Brady, Vinod Vathipadiekal, Heather A. Lankes, Robert Coleman, Mark A. Morgan, Robert Mannel, S. Diane Yamada, David Mutch, William H. Rodgers, Michael Birrer, David M. Gershenson

Research output: Contribution to journalArticlepeer-review

314 Scopus citations

Fingerprint

Dive into the research topics of 'Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: An open-label, Single-arm, Phase 2 study'. Together they form a unique fingerprint.

Medicine & Life Sciences